In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ekos Corp.

Division of Boston Scientific Corp.
www.ekoscorp.com

Latest From Ekos Corp.

A Chance To Own The Venous Space: BTG Acquires Novate

Complications with inferior vena cava (IVC) filters and subsequent patient-injury lawsuits have made this a tricky space for medical technology innovators, but BTG has not been deterred. The UK company has entered the fray with a technology developed by Novate Medical, and as a bioconvertible product BTG believes it has key advantages compared with other offerings. 

Innovation Surgical Procedures

BTG Has The Firepower For Its Next Steps In Interventional Med

UK-listed BTG PLC shares the UK life science industry's concerns about long-term negative fallout from Brexit, but it finds itself in a relatively comfortable position. The acquisitive interventional medicines company says it has plenty of firepower for more M&A.

Growth Deals

BTG Deals Its Way Into Interventional Medicine

UK-listed BTG PLC is on a route to a major future in interventional medicine, having built solid foundations in licensing and specialty pharma. CEO Louise Makin describes the deal- and decision-making rationale that has allowed a mid-cap player to set billion-dollar plus ambitions in interventional medicine, based on organic and M&A growth.

Business Strategies M & A

U.S. Approval, Sales Milestones Could Double PneumRx Price For BTG

Contingency payments based on regulatory and sales milestones for lead emphysema product RePneu could double the price BTG pays for U.S. biotech PneumRx, the latest addition to the United Kingdom company’s interventional medicines business.

Medical Device Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Boston Scientific Corp.
  • Senior Management
  • Robert Hubert, Pres. & CEO
    Matt Stupfel, VP, Fin. & Admin.
  • Contact Info
  • Ekos Corp.
    Phone: (425) 415-3100
    11911 N. Creek Pkwy. S.
    Bothell, WA 98011
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register